Special Opportunities Report
This is a paid advertisement on behalf FendX Technologies Please refer to “Forward-Looking Statements and Legal Disclaimers” at the bottom of our featured report for important information.
"This Little-Known Nanotech Company Could Be Our Top Pick For 2024"
With 80% of common infections spread through touch, the world is desperate to find solutions to help stop the spread of harmful pathogens. [26]
FendX Technologies Inc.’s (Ticker: FDXTF) award-winning nanotechnology repels viruses and bacteria, including even the strongest superbugs… providing the potential to help keep surfaces safer to touch.
Find out more about why we think this could be our top pick for 2024…
Company Info:
Name:
FendX Technologies Inc.
Ticker:
FDXTF
Website:
www.fendxtech.com
Report Highlights:
Watch Investing Insider’s Special Video on FendX Technologies on Youtube:
In the following report, you’ll discover why the growing antimicrobial coating industry – and a company named FendX Technologies Inc. (ticker FNDX on the CSE) – is worth learning more about…
You’ll see how FendX’s patent-pending non-stick film and spray products in development use nanotechnology inspired by the Lotus Leaf to repel viruses and bacteria…
How its design beat out engineers from over 60 countries and was described as ‘the most innovative invention to have a positive impact on the future’…
And how it could be applied to a variety of different surfaces, offering instant protection to reduce the spread of bacteria and viruses…
Listen, being able to control the spread of potentially harmful pathogens through society is one of our most challenging problems.
FendX’s solutions in development repel microbes and have the potential to help significantly reduce their spread at the nano-level.
It could be a key weapon to contribute in the battle against the growing global threat of pathogen transmission.
And you have the opportunity to learn more about FendX’s potentially breakthrough nanotechnology today.
One of the Greatest Threats Facing Humanity
The spread of pathogens is a potentially deadly problem that’s only getting worse…
As the world population grows, population centers are becoming denser. That means people are living closer together than ever before – and more likely to spread germs through common surfaces you touch such as handrails and door handles.
What’s worse, the overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, or “superbugs”. These treatment-resistant microbes are becoming more common and potentially lethal.
- In fact, the National Health Institute calls antimicrobial resistance a “Global Health Emergency”[2].
- UK health officials recently warned, “antimicrobial resistance was a “hidden pandemic” that could emerge in the wake of Covid-19…[3]
- And the World Health Organization calls antimicrobial resistance one of the top 10 global public health threats facing humanity – right up there with Ebola, HIV, and noncommunicable diseases such as diabetes, cancer and heart disease.[4][5]
That’s not all…
Many treatment-resistant superbugs are spread inside of what’s thought to be a safe environment: hospitals, long-term care facilities, and senior’s homes.
In fact, the CDC estimates on any given day, a shocking 1-in-31 hospital patients acquire a hospital-borne infection (i.e. an infection acquired while being treated in a medical facility).[6]
The direct medical costs associated with these infections are massive, totaling at least $28.4 billion each year. They also account for an additional $12.4 billion in costs to society from early deaths and lost productivity.[7]
And with new virus strains emerging and increasing antibiotic resistant bacteria, there’s a growing demand for innovative solutions to protect against their spread.
That’s where FendX Technologies (FDXTF) comes in…
FendX Technologies is pioneering a potential breakthrough in the antimicrobial surface coating market.
Inspired by water-resistant lotus leaves, the technology consists of nanoscopic wrinkles 1,000 times smaller than a human hair.
These wrinkles create a nanostructure surface which liquids, blood, bacteria, viruses – almost anything – essentially can’t stick to.
The technology was originally discovered by scientists at the famed McMaster University. It’s been detailed in several academic journals, including the prestigious ACS Nano. And it’s backed by a growing pending patent portfolio.
It’s also been featured on major news and media outlets such as USA Today, CNN Health, CBC, and Science Daily:
- USA Today says FendX is “pioneering a potential breakthrough in antimicrobial coatings.” [27]
- CNN Health says, “Researchers have developed a self-cleaning plastic wrap that repels bacteria and could be used to prevent the transfer of antibiotic resistant superbugs, and other forms of dangerous bacteria.” [9]
- CBC says, “Scientists engineer self-cleaning surface that can repel dangerous bacteria” [10]
- And Science Daily reports it’s a “self-cleaning surface that repels even the deadliest superbugs.”[11]
Now, to be clear, this technology is still in the development testing phase. Lab tests at McMaster have been successful, and lab prototypes have been produced. But it’s not yet available on the market however – there’s still work to be done.
But think of the potential if it’s successful…
We’re talking about a technology that could be deployed all over the world.
It could make life safer for you, your children, the elderly and millions of others.
And as an investor, it commands your immediate attention.
The potential opportunity for FendX Technologies Inc. (Ticker: FDXTF) could be significant.
How FendX Technologies Could Help Prevent the Spread of Disease
Viruses and bacteria are all around us… on door handles, grocery carts, store checkout stations, payment machines, bathroom sinks/taps, railings, elevator buttons and more.
They cling, grow and thrive on everyday surfaces like glass, paper, and metal. And they can survive for days… weeks… even months unless disinfected.
In fact, studies have shown that:
- The influenza virus can survive for up to 17 days on things like banknotes[13]…
- Some bacteria – including deadly E. Coli and MRSA – can survive for months on inanimate surfaces.[14]
- And the COVID-19 causing SARS-CoV-2 virus can survive for 28 days on glass, paper, and steel.[15]
FendX’s lead product in development, REPELWRAP™ film, is a protective surface coating that has been shown in McMaster’s lab to significantly reduce pathogen transmission.
FendX’s second product is a Spray Coating that could potentially be easier to apply and open new markets.
Both products utilize the company’s proprietary repel nanotechnology and can be applied to many different surfaces, offering 24-7 protection without the need for continuous disinfecting.
In fact, based on McMaster lab testing, the repel rates against potentially deadly pathogens are impressive:
- REPELWRAP: Greater than 99% reduction in the adhesion of COVID-19 like viruses, MRSA, and E. Coli…
- Spray Coating: Greater than 98% reduction in the adhesion of COVID-19 like viruses, MRSA, and E. Coli… [16]
Because of the unique “repel” ability, REPELWRAP™ film attacks the problem of pathogen spread differently than anything else on the market today.
FendX’s REPELWRAP™ film offers instant, 24-7 protection without the need for continuous disinfecting.
One of the biggest differences is that other protective coating films require viruses and bacteria to attach to their surface to be killed. However, it takes time to kill those pathogens that attach… allowing them an opportunity to potentially be passed on to unsuspecting individuals when they touch it.
For example, some competitors’ films contain silver or copper that can kill pathogens. But that process can take up to a few hours to effectively kill all viruses or bacteria.[18]
This creates a “window of transmission” where contaminated surfaces can spread infections – especially in high-traffic touch point areas.
These metal containing surfaces could also lead to bacterial resistance – making the surface ineffective to these resistant strains.
In contrast, FendX’s REPELWRAP™ film uses nano-scale engineering to create a surface that pathogens can’t attach to. Since pathogens can’t attach, they can’t replicate and be passed on.
This means that if a REPELWRAP™-coated surface is touched with a contaminated hand, there is smaller chance for this contamination to spread.
Because REPELWRAP is a thin flexible film, it can be applied to flat surfaces, railings, push doors, curved door handles, and more.
FendX is also working on developing a spray coating version of this repel technology.
When sprayed onto a surface, it forms a protective film coating similar to REPELWRAP™ film with the same repelling properties.
It also has a secondary benefit of killing residual pathogens on the coated surface.
As well, a potential spray product could be easier to apply to many surfaces and may expand potential market applications.
FendX is collaborating with McMaster to further develop the spray nanotechnology as we speak.
FendX’s Film and Spray Nanocoatings have Many Potential Advantages (as shown in the lab):
- Significantly reduces the transfer of deadly pathogens like MRSA, E-Coli, COVID-19 related viruses…
- Works instantly…
- Can cover many different surface types…
- And offers 24-7 protection.
The Antimicrobial Nano-Coating Market Potential
Future Markets Inc. estimates the antimicrobial coatings market size will grow to $1.3 billion by 2026, up from only $800 billion in 2022. [19]
The size and growth of the antimicrobial nano-coating market offers a significant opportunity for FendX (should REPELWRAP™ film and the spray coating formulation successfully be scaled-up to larger intermediate size films and be successful in commercial scale-up manufacturing).
As mentioned earlier, approximately 1-in-31 hospital patients get a healthcare-associated infection. That’s a huge number of people being exposed to harmful pathogens in what’s “supposed” to be considered a safe environment.
These pathogens can also be life-threatening for vulnerable and compromised persons.
- In fact, the World Health Organization claims that 1 in 10 patients who get a healthcare-associated infection will die worldwide[20]… while Oxford Academic estimates these infections are the fourth leading cause of death in the United States.[21]
It’s staggering and scary. But what’s worse is this…
Contaminated surfaces and equipment are some of the most common sources of infection according to the National Health Institute. [22]
It finds that contact transmission – when an infected patient comes in direct contact with another or contaminates a surface like a doorknob – is the one of the frequent modes of transmission in the health care setting.
FendX’s proprietary film and spray-on nano-coatings could be used on high-touch surfaces such as bed rails, doorknobs, and other surfaces to help reduce pathogen transmission.
Just think about how many public surfaces you come into contact with each day…
More Reasons to Learn More about FendX Technologies (FDXTF)
As FendX continues its product development, we may see it used to protect surfaces in other high traffic places like the transportation, sports and entertainment, hospitality, and education sectors.
Take public transport for instance.
Millions of people use public transportation everyday – touching railings, handles and more. But how often do you see them being sanitized?
Then there’s education centers like schools and universities.
There are over 200,000 primary and secondary schools in North America, Europe, and Japan.[23] [24] [25]
Protecting high traffic touch point like door handles and railings, and preventing the transmission of pathogens in the education system could be a key focus in reducing spread.
And let’s not forget public places like stadiums, malls, restaurants and entertainment centers…
Preventing the transfer of pathogens in public settings is important to control the spread of disease… and keeping surfaces clean in these sectors is not always possible.
But, as mentioned above, the company does not yet have a commercial product…
The film and spray nanotechnologies were licensed from McMaster University and the film and spray prototypes have been tested successfully in their labs.
REPELWRAP™ film is currently in intermediate scale-up with Dunmore International, Corp, a Steel Partners Holdings L.P. (NYSE:SPLP) company.
The spray coating is being assessed and will enter intermediate scale-up manufacturing with nanoComposix, LLC, a Fortis Life Science Company.
Both of these engagements are important milestones for the company as the company advances their film and spray products.
In collaboration with Dunmore, the company successfully automated the manufacturing process of REPELWRAP™ film to create intermediate-sized prototypes. It also continues to refine the manufacturing process in additional trial manufacturing runs for testing including real world conditions testing.
Success of these milestones should position FendX to potentially begin commercial scale-up manufacturing.
FendX’s patent-pending technology has the potential to enter a big antimicrobial nano-coating market contributing towards solving the global threat of pathogen transmission.
There are several multi-million-dollar industries that could benefit from innovative products to control the spread of pathogens. FendX’s film and spray nanotechnology may have the potential to play a role in many of these industries.
Do your own research now.
Antimicrobial nano-coating is a promising, high-growth industry. And FendX is positioning itself to take advantage of this opportunity.
Given the for the need for innovative products to contribute to reducing the spread of pathogens…
The heightened awareness of pathogen transmission…
And the growing number of healthcare-associated infections…
Investors would be wise to closely evaluate FendX Technologies Inc. (Ticker: FDXTF) as potential future key player in the race to reduce the spread of bacteria and viruses.
Frequently Asked Questions:
Yes! FendX Technologies trades on the OTCQB under the ticker FDXTF. It also trades on the Canadian Securities Exchange under the ticker FNDX.
Yes, FendX has filed over ten patent applications to date. It also recently announced that its Chinese patent # ZL 202080055337.6 was granted.
FendX’s technology is distinct because it prevents pathogens from attaching to surfaces. Unlike other films that require pathogens to attach before being killed, which can create a window of transmission, FendX’s REPELWRAP™ film uses nanoscale engineering to create surfaces that instantly repel such that pathogens cannot adhere, thereby reducing the risk of transmission.
REPELWRAP™ film has shown impressive results in lab tests. It has been shown to significantly reduce the amount of viral particles, like those related to COVID-19, MRSA, E. coli and B. subtillis by more than 99%.
FendX’s technology has the potential to be used in several applications including healthcare facilities, public transportation, schools, offices, and other high-traffic areas.
FendX is currently in the product development stage. The technology, licensed from McMaster University, has been successfully tested in labs and recently confirmed the REPELWRAP™ film formulation can be scaled-up and is suitable for automated manufacturing, moving it closer to potential commercial production. Should intermediate scale-up and commercial scale production activities be achieved, the company intends to launch REPELWRAP™ film in Canada in the second half of 2024.
Contact Your Broker and Ask About FDXTF Today
Common brokerage houses include:
1) Nanotechnology with Repelling Properties:
FendX’s nanotechnology, inspired by the water-resistant lotus leaves, consists of nanoscopic wrinkles that are a billion-times smaller than what can be seen with the human eye.
These wrinkles create a unique topography that bacteria, viruses – almost anything – can’t stick to. It works instantly and offers 24-7 protection, addressing the growing need for new products to contribute to continuous protection of surfaces prone to contamination to reduce the spread of bacteria and viruses.
2) Potential Multi-Million-Dollar Markets:
Global infections continue to be difficult to control despite efforts to contain their spread. This is increasing the demand for innovative and effective infection control measures.
FendX has the potential to be adopted across various high-traffic public settings such as healthcare facilities, public transportation, schools, and offices. The sheer size and diversity of the target market has the potential to present a large future growth opportunity.
3) New Spray Product in Development:
FendX is working with McMaster University to develop a spray coating version of REPELWRAP™ film using its unique nanotechnology which may prove to be easier to apply to many surfaces and may expand potential market applications.
4) Different From Other Antimicrobial Coating Films:
FendX’s pathogen-repelling technology is different than other films on the market today.
Other films require viruses and bacteria to attach to their surface to be killed, creating a potential “window of transmission” where bacteria or viruses on the film can still be spread.
FendX uses nanoscale engineering to create surfaces that pathogens can’t attach to. Since pathogens can’t attach, they’re hard to pass on.
5) Timely and Relevant:
6) Future, Untapped Industries May Add Potential:
FendX’s nanotechnology has the potential to be applied to other types of surfaces and materials – such as catheters which could significantly help reduce blockages caused by blood clot formation or bacterial infections in long-use catheters.
Underserved markets like this offer potential future upside if the company can successfully adapt their nanotechnology.
7) Preparing for Potential Commercial-Scale Production:
FendX just successfully completed its second production trial-run with Dunmore International, potentially paving the way to commercial-scale production.
Download a free investor information package:
By requesting an investor information package, you agree to our Privacy Policy & Terms, and agree to receive periodic emails from Investing Insider and our partners. You can opt out at any time.
FendX Technologies Inc General Disclaimer
This article contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface and coating market, overall market growth rates and the Company’s growth rates and growth strategies; the frequency of common infections spread by touch, microbe repellent technology is a promising, high-growth industry; the use of available funds; the performance of the Company’s business and operations; the Company’s expectations regarding revenues, expenses and anticipated cash needs; the intention to grow the Company’s business and operations; the expected timing and completion of the Company’s near-term objectives; laws and regulations and any amendments thereto applicable to the Company; the Company’s competitive advantages and business strategies; the Company’s future product offerings, including potential new applications (i.e. catheters) and new formulations (i.e. spray); the Company’s research and development initiatives and expected results thereof; the Company’s growing patent portfolio; the Company entering into distribution, manufacturing and other business relationships, in Canada, the United States, and globally; the potential of the Company’s technology to protect against the spread of pathogens on surfaces through repelling bacteria and viruses that come in contact with its surface; that the Company’s technology will bring significant value in controlling the spread of surface borne infectious diseases; trends regarding healthcare-acquired infections; proprietary REPELWRAP™ film could be used on high-touch surfaces such as bed rails, doorknobs, and medical devices to help prevent pathogen transmission; the Company’s nanotechnology has the potential to be applied to other types of surfaces and materials –such as catheters which could significantly help reduce blockages caused by bacterial colony and/or blood clot formation in long-use catheters and that underserved markets like this offer potentially future upside, if the Company can successfully adapt their technology; the Company’s intention to initially target REPELWRAP™ film towards healthcare settings and high traffic public touchpoints; that as the Company continues its product development, we may see it used to protect surfaces in other high traffic places like the transportation, education, sports and entertainment sectors; the growing global commitment to reduce the spread of pathogens; the development of the Company’s spray nanotechnology, which could be easier to apply to many surfaces and expand potential market applications; the Company’s organic growth strategy and expansion strategy; line extensions for REPELWRAP™ film; further development of core technology into additional applications (i.e. catheters); expansion into vertical markets; licensing of additional nanotechnology formulations and/or complementary products that reduce pathogen spread; potential licensing, M&A and partnerships within the infectious disease space; and that REPELWRAP™ film will provide additional protection to current disinfecting practices to control the spread of pathogens.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history, no revenues and uncertainty around additional financing; negative cash flow history; no production history and lack of revenues from sales; no history of manufacturing or distribution; highly competitive industry; satisfying the terms of the License Agreement, Spray License Agreement and Collaborative Research Agreements between the Company and McMaster University and maintaining licenses in good standing; inability of McMaster University to satisfy the terms under the License Agreement, Spray License Agreement and Collaborative Research Agreements; ability to successfully complete of scale-up and development of commercial film, spray and other products; research and development activities; reliance on grant funding; limited number of products; dependence on collaborative partners, licensors and others; no formal manufacturing or distribution agreements in place; changes and restrictions due to legal and regulatory requirements; dependence on each product’s acceptance in the market; possibility of smaller market opportunities than anticipated; increasing regulatory and compliance costs for public companies; global economic instability; product liability claims and lawsuits; system failures; reliance on management and loss of key employees or inability to hire key personnel; limited experience of senior management in managing a public company; fraudulent or illegal activity by employees, contractors and consultants; inability to effect service of process on some of the Company’s directors and officers; management’s efforts and abilities; potential conflicts of interest; inability to protect intellectual property rights; inability to secure patents or grow its patent portfolio; infringement on proprietary rights of third parties; risks related to forward-looking information; volatility of the market price of the Company’s common shares; potential dilution of the common shares; lack of an active, liquid and orderly trading market for the common shares; failure of securities or industry analysts to publish research or publish inaccurate or unfavorable research about the Company; inability or unwillingness to pay dividends; exchange rate fluctuations between the Canadian dollar and the U.S. dollar; effect of COVID-19 public health crisis or another global health pandemic; use of available funds; effect of general economic and political conditions; internal controls; and other risk factors and potential effects set forth in the Company’s public filings, publicly available through the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedarplus.ca for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any Forward-looking statements contained in this presentation are expressly qualified in their entirety by this cautionary statement.
While the information contained in this presentation is believed to be accurate, the Company expressly disclaims any and all liability for any losses, claims or damages of whatsoever kind based upon the information contained in, or omissions from, this presentation or any oral communication transmitted in connection therewith. In addition, none of the statements contained in this presentation are intended to be, nor shall be deemed to be, representations or warranties of the Company. Where the information is from third-party sources, the information is from sources believed to be reliable, but the Company has not independently verified any of such information contained herein.
This presentation is not, and under no circumstances is to be construed as, a prospectus, an offering memorandum, an advertisement or a public offering of securities. Under no circumstances should the information contained herein be considered an offer to sell or a solicitation of an offer to buy any securities.
[1] https://brighterworld.mcmaster.ca/articles/the-ultimate-non-stick-coating/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486712/
[3] https://www.bbc.com/news/health-60058120
[4] https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
[5] https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
[6] https://www.cdc.gov/policy/polaris/healthtopics/hai/index.html
[7] https://www.cdc.gov/policy/polaris/healthtopics/hai/index.html
[8] Future Markets Inc., January 2023
[9] https://www.cnn.com/2019/12/13/health/superbug-repelling-surface-intl-scli-scn/index.html
[10] https://www.cbc.ca/radio/quirks/feb-15-agriculture-moving-north-arrokoth-s-secrets-the-microbiome-for-flight-and-more-1.5463847/canadian-scientists-engineer-self-cleaning-surface-that-can-repel-dangerous-bacteria-1.5463857
[11] https://www.sciencedaily.com/releases/2019/12/191213123554.htm
[12] https://brighterworld.mcmaster.ca/articles/mcmaster-inventors-repellent-wrap-shown-to-shed-all-viruses-and-bacteria/
[13] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394922
[14] https://www.bbc.com/future/article/20200529-the-surfaces-that-kill-bacteria-and-viruses
[15] https://www.cnbc.com/2020/10/12/virus-that-causes-covid-19-can-survive-for-28-days-on-surfaces-research-says.html
[16] https://fendxtech.com/ – Investor Deck January 2024
[17] https://cosmosmagazine.com/technology/materials/repelwrap-repels-viruses/
[18] https://www.biocote.com/frequently-asked-questions/
[19] Future Markets Inc., January 2023
[20] https://www.who.int/news/item/06-05-2022-who-launches-first-ever-global-report-on-infection-prevention-and-control
[21] https://academic.oup.com/cid/article/53/7/i/424554
[22] https://www.ncbi.nlm.nih.gov/books/NBK2683/
[23] https://www.weareteachers.com/how-many-schools-are-in-the-us
[24] https://factsanddetails.com/japan/cat23/sub150/entry-2799.html
[25] https://askwonder.com/research/total-number-high-schools-also-known-secondary-schools-universities-known-j4lribx4j
[26] http://www.bccdc.ca/health-info/prevention-public-health/hand-hygiene
[27] https://www.usatoday.com/story/special/contributor-content/2023/11/28/how-the-lotus-leaf-inspired-the-creation-of-a-new-and-unique-innovation-in-medical-technology/71728839007/
FEATURED NEWS:
VIDEO:
VIDEO:
FDXTF : OTCQB
FNDX : CSE
E8D : FSE
Download a free investor information package
Simply fill out the form below:
By requesting an investor information package, you agree to our Privacy Policy & Terms, and agree to receive periodic emails from Investing Insider and our partners. You can opt out at any time.
FENDX RECENT NEWS:
January 24, 2023
December 13, 2023
November 29, 2023
November 1, 2023
October 26, 2023
October 3, 2023
July 20, 2023
June 21, 2023
May 25, 2023
May 17, 2023
